Why the study?
Is single-stage surgery combining abdominal aortic aneurysm repair and MIDCAB safe and effective in patients with concomitant coronary artery disease?
Is single-stage surgery combining abdominal aortic aneurysm repair and MIDCAB safe and effective in patients with concomitant coronary artery disease?
Single-stage surgery combining AAA repair and MIDCAB appears feasible and safe, with no hospital mortality and 100% short-term graft patency in a small case series.
Single-stage AAA repair with MIDCAB may be feasible in select patients; leaves open need for prospective data before wider adoption.
腹部大動脈瘤症例に冠動脈病変を合併することは珍しくないが，確立した治療方針はまだない．一期的に外科的冠血行再建と腹部手術を行うさいには，その手術侵襲が問題となる．今回我々は，4例の冠動脈病変合併腹部大動脈症例に対し，侵襲度の低減のために冠血行再建をmidcabで行った．平均手術時間は399分，平均冠動脈バイパス吻合枝数1.75，全例術当日か翌日に抜管可能で，退院日は術後平均29.3日後であった．手術死亡，病院死亡は認めなかった．術後評価は全例造影ctで行い，冠動脈バイパスは全て開存していた．以上，冠血行再建にmidcabを用いて腹部大動脈瘤同時手術を行い良好な結果を得たので，文献的考察を加えて報告する．
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: